S-1/A: Change Agents Corp. Files for Resale of Over 5.3M Shares

Change Agents Corporation is registering for resale by selling stockholders up to 5,360,797 shares of its common stock, detailing ongoing financial challenges and strategic shifts.

Summary

• Change Agents Corporation (formerly Avalon GloboCare Corp.) is filing an S-1/A amendment to register for resale by selling stockholders up to 5,360,797 shares of its common stock.
• The filing details the company's ongoing financial challenges, including a significant accumulated deficit and a going concern warning from its auditors.
• The company is pivoting its business strategy, focusing on AI-driven software (agentic AI video generation and search optimization) and consumer health products (Keto Air breathalyzer).
• Recent financing activities include various debt issuances and preferred stock financings, alongside a 1-for-20 reverse stock split.
• The company has also announced plans to expand into AI-enhanced drone interception and surveillance technology through a new subsidiary.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the company's ongoing financial struggles, significant accumulated deficit, and reliance on future financing, despite efforts to pivot to AI technologies.

Positives

• Strategic pivot towards AI technologies, including agentic AI video generation and search optimization, and expansion into drone interception and surveillance.
• FDA registration for the Keto Air breathalyzer device, a non-invasive consumer health product.
• Recent name change to Change Agents Corporation and ticker symbol change to CHGA to reflect strategic evolution.
• The company has filed provisional patent applications related to its AI platform technology.

Negatives

• The company has a history of net losses and an accumulated deficit of approximately $112.6 million as of June 30, 2026, raising substantial doubt about its ability to continue as a going concern.
• As of September 11, 2026, the company had approximately $172,000 in cash, insufficient to cover 12 months of operations, requiring at least $5,000,000 in additional cash.
• The company has approximately $2.7 million in outstanding indebtedness as of September 11, 2026.
• The company has not generated sustainable revenue since inception and anticipates it will take approximately one year to generate meaningful revenue from its Catch-Up platform.
• The ELOC Purchase Agreement allows for potential dilution through the sale of up to 5,000,000 Put Shares to Hudson Global Ventures, LLC at a fixed price of $2.00 per share.

Risks

• The company has a limited operating history in its current business segments, making future prospects difficult to evaluate.
• The company has a history of net losses and an accumulated deficit, raising substantial doubt about its ability to continue as a going concern.
• The company's current cash balance is insufficient to support operations for the next 12 months.
• The company has outstanding indebtedness that could adversely affect its financial condition and liquidity.
• The company may not be successful in commercializing its AI platform or its Keto Air product.
• The use of AI in its platform may give rise to legal liability, reputational harm, and regulatory scrutiny.
• Laws and regulations governing artificial intelligence are rapidly evolving, and compliance may be costly and uncertain.
• The company must maintain compliance with Nasdaq continued listing standards, and there can be no assurance that it will be able to do so.

Future Outlook

The company anticipates needing to raise additional capital to fund its operations and growth, including research and development, marketing, and general corporate purposes. Future issuances of securities could result in substantial dilution to existing stockholders. The company expects its cash used in operating activities to increase in the next 12 months due to product development and commercialization efforts.

Management Comments

• We believe our diverse and evolving portfolio of commercial activities reflects our ongoing commitment to identifying and building value-oriented technology businesses for the benefit of its stockholders.
• We are actively seeking complementary bolt-on AI acquisitions that could generate near-term revenue to supplement our current operations as both segments continue to develop.

Industry Context

StockSavvy.ai notes that the company's strategic shift towards AI aligns with broader industry trends, particularly in generative AI and AI-powered search, as highlighted by McKinsey & Company's report on AI search adoption. However, the company faces intense competition in both its AI and consumer health segments from established players with significantly greater resources.

Comparison to Industry Standards

• The company's AI-driven video generation platform aims to address the growing demand in the creator economy, a market experiencing substantial growth.
• The Beacon Agentic GEO search product targets small businesses, addressing a gap in AI visibility noted by industry reports.
• The Keto Air breathalyzer competes in the consumer health market against urine test strips and other breathalyzers, aiming for convenience and non-invasiveness.

Corporate Governance

Legal Proceedings

• Research Institute at Nationwide Children's Hospital filed a complaint alleging misappropriation of trade secrets and violation of trade secret laws, settled via a payment plan and profit-sharing agreement.

Related Party Transactions

• Sale of 100% of Avalon RT 9 Properties, LLC to Wenzhao Lu (Chairman of the Board) for approximately $9,000,000.
• Exchange of 9,000 shares of Series A Preferred Stock for 5,000 shares of Series D Preferred Stock with Wenzhao Lu.
• Consulting services provided by Wilbert Tauzin (former director) and his son.
• Lease of office space from Avalon RT 9 (owned by Wenzhao Lu) commencing March 1, 2026.
• Issuance of shares to Hudson Global Ventures, LLC under the ELOC Purchase Agreement, where Hudson is considered an underwriter.

Stakeholder Impact

• Shareholders face potential dilution from the resale of shares by selling stockholders and future capital raises.
• The company's ability to continue as a going concern may impact all stakeholders.
• The company's reliance on third-party providers for its Keto Air business could impact supply chain reliability for customers and suppliers.

Next Steps

• The company intends to seek stockholder approval for the issuance of shares underlying the ELOC Warrant by October 30, 2026.
• Phase 2 of the Catch-Up platform is expected to launch in Q3 of 2026.
• The company will continue to evaluate possible AI acquisitions.
• The company will continue to maintain and prosecute its cellular therapy patents.

Key Dates

Recommendation

The company exhibits significant financial distress, including a going concern warning, substantial accumulated deficit, and insufficient cash reserves. While the pivot to AI is strategically sound, the immediate financial realities and the potential for significant dilution from the ELOC Purchase Agreement present substantial risks that outweigh the speculative upside from new technologies in the near term.

Keywords

AI software, Agentic AI, video generation, search optimization, consumer health, breathalyzer, Keto Air, drone surveillance